Drug-maintained behavior serves as an appropriate model to assess potential treatments for drug abuse. Recent studies have shown that agonist treatments can decrease responding maintained by cocaine, or opiates. These effects have been shown to be persistent, and without deleterious consequence. They are interpreted as a substitution effect, similar to that expected of methadone for heroin abuse and nicotine patches for tobacco abuse. Confirmation of this notion may lead to the development of agonist treatments for other forms of substance abuse. The utility of this approach is that compliance is expected to be greater than that seen with antagonist-based treatments. in addition, agonists only decrease drug-intake, while increases in drug intake have been observed with antagonists. Preliminary clinical reports suggest that agonists exhibit efficacy in humans. Nevertheless, this form of treatment deserves more study before being implemented. One reason is that other forms of treatment may be more efficacious. For example, some studies have shown that providing access to non-drug reinforcers can also decrease drug- maintained responding. Another reason is that few studies have addressed the therapeutic ratio for agonist effects, nor the range of conditions under which drug-seeking can be decreased. The current studies are designed to more fully assess the nature of agonist treatments on drug- maintained behavior. In doing so, several issues related to obtaining a better understanding of determinants of the reinforcing efficacy of drugs will be addressed. Traditional methods of determining the reinforcing effects of drugs have been limited to either the extent to which different doses will support higher ratio requirements,or the assessment of rates of responding maintained by different doses of a drug. While the former has been criticized for a lack of stability, the latter is rarely accomplished due to the large amount of data required. Recently, it has been suggested that these two indices can be combined to describe a single function relating reinforcing effects of drugs behavioral output per dose. This possibility would allow a using a more rapid assessment of agonist effects on drug- maintained behavior, if limited data sets can adequately describe this function. The initial studies of the proposal seek to address this issue by comparing these measures of reinforcing efficacy of drugs, using cocaine and fentanyl. Subsequent studies will use these measures to address: l) the nature of the ability of agonists to decrease drug- maintained responding, 2) the relationship between reinforcing efficacy of the treatment drug and the drug for which treatment is sought, 3) the relative abilities of treatment drugs to decrease food- and drug- maintained responding, 4) the ability of agonists from other classes of drug reinforcers as well as receptor-specific agonists and antagonists, to affect drug-maintained responding, 5) how these measures compare with other measures of relative reinforcing efficacy of drugs, and 6) ways in which agonist treatment can be used to permanently decrease drug- maintained behavior.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA009820-03
Application #
2013379
Study Section
Special Emphasis Panel (SRCD (27))
Program Officer
Lynch, Minda
Project Start
1995-07-01
Project End
1999-05-31
Budget Start
1997-07-01
Budget End
1999-05-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Louisiana State University Hsc Shreveport
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Shreveport
State
LA
Country
United States
Zip Code
71103
Stafford, D; LeSage, M G; Rice, K C et al. (2001) A comparison of cocaine, GBR 12909, and phentermine self-administration by rhesus monkeys on a progressive-ratio schedule. Drug Alcohol Depend 62:41-7
Stafford, D; Rice, K C; Lewis, D B et al. (2000) Response requirements and unit dose modify the effects of GBR 12909 on cocaine-maintained behavior. Exp Clin Psychopharmacol 8:539-48
LeSage, M G; Stafford, D; Glowa, J R (1999) Preclinical research on cocaine self-administration: environmental determinants and their interaction with pharmacological treatment. Neurosci Biobehav Rev 23:717-41
Wojnicki, F H; Rothman, R B; Rice, K C et al. (1999) Effects of phentermine on responding maintained under multiple fixed-ratio schedules of food and cocaine presentation in the rhesus monkey. J Pharmacol Exp Ther 288:550-60
Stafford, D; LeSage, M G; Glowa, J R (1999) Effects of phentermine on responding maintained by progressive-ratio schedules of cocaine and food delivery in rhesus monkeys. Behav Pharmacol 10:775-84
Stafford, D; LeSage, M G; Glowa, J R (1998) Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology (Berl) 139:169-84
Glowa, J R; Fantegrossi, W E (1997) Effects of dopaminergic drugs on food- and cocaine-maintained responding. IV: Continuous cocaine infusions. Drug Alcohol Depend 45:71-9
Glowa, J R; Rice, K C; Matecka, D et al. (1997) Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys. Neuroreport 8:1347-51
Glowa, J R; Wojnicki, F H (1996) Effects of drugs on food- and cocaine-maintained responding, III: Dopaminergic antagonists. Psychopharmacology (Berl) 128:351-8
Glowa, J R; Fantegrossi, W E; Lewis, D B et al. (1996) Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate, a long-acting ester derivative of GBR 12909. J Med Chem 39:4689-91